SOFI vs TERN · P/E 39, rev $619.4M vs $6.12B cap
SoFi Technologies Inc. (SOFI) versus Terns Pharmaceuticals Inc (TERN) — a side-by-side from cached financials, not a winner call.
SoFi Technologies Inc. (SOFI) is a credit services company listed on NASDAQ.
Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
Latest reported SOFI revenue for 2025-12-31 was $619.4M. Net income was $481.3M. Revenue was up 23.1% from 2024-12-31 to 2025-12-31. SOFI currently screens at market cap $22.25B and trailing P/E 38.5.
Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. TERN currently screens at market cap $6.12B.
SOFI currently screens at market cap $22.25B and trailing P/E 38.5. TERN currently screens at market cap $6.12B.
Not investment advice. Open the SOFI and TERN stock pages for the full models.
Not investment advice.